IBM and Cellomics Create Affordable Technology Solution to Accelerate Cell-Based Drug Discovery
First High-Content Screening and Analysis Solution Being Used by Bio-Pharmaceutical Researchers at EPOPLUS to Identify Off-Target Effects in Live Cells
11-Aug-2004 -
Somers and Pittsburgh. IBM and Cellomics, Inc., a leader
in creating software and hardware tools for High Content Screening (HCS), today announced
they have launched a customized information technology (IT) solution that allows biopharmaceutical scientists and academic researchers to better ...
biology
biopharmaceuticals
diseases
+8